Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity

Kidney International

Volumn 72, Issue 8, 2007, Pages 985-993

  Prozialeck, W C ^a   Vaidya, V S ^b   Liu, J ^c   Waalkes, M P ^c   Edwards, J R ^a   Lamar, P C ^a   Bernard, A M ^d   Dumont, X ^d   Bonventre, J V ^b,e  

^a MIDWESTERN UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Biomarkers; Cadmium; Clara cell protein (CC 16); Kim 1; Metallothionein; Nephrotoxicity

Indexed keywords

BIOLOGICAL MARKER; CADMIUM; CLARA CELL PROTEIN; CREATININE; KIDNEY INJURY MOLECULE 1; MEMBRANE PROTEIN; METALLOTHIONEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CADMIUM POISONING; CONTROLLED STUDY; CREATININE CLEARANCE; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MALE; MOLECULE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEINURIA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; URINALYSIS;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; CADMIUM; CELL ADHESION MOLECULES; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY TUBULES, PROXIMAL; MALE; MEMBRANE PROTEINS; METALLOTHIONEIN; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; UTEROGLOBIN;

EID: 34948883334     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002467     Document Type: Article

References (82)

1. Bernard A, Lauwerys R. Cadmium in human population. Experientia 1984; 40: 143-152.
2. Fassett DW. Cadmium: biological effects and occurrence in the enviroment. Annu Rev Pharmacol 1975; 15: 425-435.
3. Jarup L, Berglund M, Elinder CG et al. Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand J Work Environ Health 1975; 24(Suppl 1): 1-51.
4. Morselt AF. Environmental pollutants and diseases. A cell biological approach using chronic cadmium exposure in the animal model as a paradigm case. Toxicology 1991; 70: 1-132.
5. Degraeve N. Carcinogenic, teratogenic and mutagenic effects of cadmium. Mutat Res 1981; 86: 115-135.
6. Elinder CG, Kjellstrom T. Carcinogenic and mutagenic effects. In: Friberg L, Elinder CG, Kjellstrom T, Nordberg GF (eds) Cadmium and Health: a Toxicological and Epidemiological Appraisal, (vol 1). CRC Press: Boca Raton, FL, 1986, pp 205-229.
7. Waalkes MP, Coogan TP, Barter RA. Toxicological principles of metal carcinogenesis with special emphasis on cadmium. Crit Rev Toxicol 1992; 22: 175-201.
8. Friberg L. Cadmium and the kidney. Environ Health Perspect 1984; 54: 1-11.
9. Kjellstrom T. Renal Effects. In: Friberg L, Elinder C-G, Kjellstrom T, Nordberg GF (eds). Cadmium and Health: a Toxicological and Epidemiological Appraisal, (vol 2). CRC Press: Boca Raton, FL, 1986 pp 21-109.
10. Lauwerys RR, Bernard A, Roels HA et al. Characterization of cadmium proteinuria in man and rat. Environ Health Perspect 1984; 54: 147-152.
11. Piscator M. The nephropathy of chronic cadmium poisoning. In: Foulkes EC (ed). Cadmium, Handbook of Experimental Pharmacology, vol 80.. Springer-Verlag: New Yor, 1986, pp 194-197.
12. Akesson A, Lundh T, Vahter M et al. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect 2005; 113: 1627-1631.
13. Friedman LS, Lukyanova EM, Kundiev YI et al. Anthropometric, environmental, and dietary predictors of elevated blood cadmium levels in Ukrainian children: Ukraine ELSPAC group. Environ Res 2006; 102: 83-89.
14. Hellstrom L, Elinder CG, Dahlberg B et al. Cadmium exposure and endstage renal disease. Am J Kidney Dis 2001; 38: 1001-1008.
15. Jarup L. Cadmium overload and toxicity. Nephrol Dial Transplant 2002; 17(Suppl 2): 35-39.
16. Abe T, Kobayashi E, Okubo Y et al. Application of path analysis to urinary findings of cadmium-induced renal dysfunction. J Environ Sci Health A Tox Hazard Subst Environ Eng 2001; 36: 75-87.
17. Bernard A. Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals 2004; 17: 519-523.
18. Mueller PW, Price RG, Finn WF. New approaches for detecting thresholds of human nephrotoxicity using cadmium as an example. Environ Health Perspect 1998; 106: 227-230.
19. Nakajima M, Kobayashi E, Suwazono Y et al. Excretion of urinary cadmium, copper, and zinc in cadmium-exposed and nonexposed subjects, with special reference to urinary excretion of beta2-microglobulin and metallothionein. Biol Trace Elem Res 2005; 108: 17-31.
20. Roels HA, Hoet P, Lison D. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity. Ren Fail 1999; 21: 251-262.
21. Shaikh ZA, Smith LM. Biological indicators of cadmium exposure and toxicity. Experientia 1986; (Suppl 50): 124-130.
22. Shaikh ZA, Ellis KJ, Subramanian KS, Greenberg A. Biological monitoring for occupational cadmium exposure: the urinary metallothionein. Toxicology 1990; 63: 53-62.
23. Bernard AM, Thielemans NO, Lauwerys RR. Urinary protein 1 or Clara cell protein: a new sensitive marker of proximal tubular dysfunction. Kidney Int Suppl 1994; 47: S34-S37.
24. Klaassen CD, Liu J. Role of metallothionein in cadmium-induced hepatotoxicity and nephrotoxicity. Drug Metab Rev 1997; 29: 79-102.
25. Klaassen CD, Liu J, Choudhuri S. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol 1999; 39: 267-294.
26. Nordberg M, Jin T, Nordberg GF. Cadmium, metallothionein and renal tubular toxicity. IARC Sci Publ 1992; 118: 293-297.
27. Nordberg M. General aspects of cadmium: transport, uptake and metabolism by the kidney. Environ Health Perspect 1984; 54: 13-20.
28. Chen L, Jin T, Huang B et al. Critical exposure level of cadmium for elevated urinary metallothionein - an occupational population study in China. Toxicol Appl Pharmacol 2006; 215: 93-99.
29. Broeckaert F, Clippe A, Knoops B et al. Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann NY Acad Sci 2000; 923: 68-77.
30. Sundin DP, Cohen M, Dahl R et al. Characterization of the beta 2-microglobulin endocytic pathway in rat proximal tubule cells. Am J Physiol 1994; 267: F380-F389.
31. Roels H, Bernard A, Buchet JP et al. Urinary excretion of beta2-microglobulin and other proteins in workers exposed to cadmium, lead or mercury. Pathol Biol (Paris) 1978; 26: 329-331.
32. Kobayashi E, Suwazono Y, Uetani M et al. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan. Environ Res 2006; 101: 401-406.
33. Lauwerys RR, Bernard AM, Roels HA, Buchet JP. Cadmium: exposure markers as predictors of nephrotoxic effects. Clin Chem 1994; 40: 1391-1394.
34. Lermioglu F, Bernard A. Effect of calmodulin-inhibitors and verapamil on the nephrotoxicity of cadmium in rat. Toxicol Lett 1998; 95: 9-13.
35. Shaikh ZA, Tohyama C. Urinary metallothionein as an indicator of cadmium body burden and of cadmium-induced nephrotoxicity. Environ Health Perspect 1984; 54: 171-174.
36. Sugihira N, Tohyama C, Murakami M, Saito H. Significance of increase in urinary metallothionein of rats repeatedly exposed to cadmium. Toxicology 1986; 41: 1-9.
37. Feigelstock D, Thompson P, Mattoo P et al. The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J Virol 1998; 72: 6621-6628.
38. Han WK, Bonventre JV. Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 2004; 10: 476-482.
39. Ichimura T, Hung CC, Yang SA et al. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004; 286: F552-F563.
40. Bailly V, Zhang Z, Meier W et al. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 2002; 277: 39739-39748.
41. Amin RP, Vickers AE, Sistare F et al. Identification of putative gene based markers of renal toxicity. Environ Health Perspect 2004; 112: 465-479.
42. Vaidya VS, Ramirez V, Ichimura T et al. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006; 290: F517-F529.
43. Goering PL, Vaidya VS, Brown RP et al. Kidney injury molecule-1 (KIM-1) expression in kidney and urine following acute exposure to gentamicin and mercury. (abstract). The Toxicologist CD - An Official Journal of the Society of Toxicology 2006; 90: S-1.
44. Perez-Rojas J, Blanco JA, Cruz C et al. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. Am J Physiol Renal Physiol 2006; 292: 131-139.
45. Dudley RE, Gammal LM, Klaassen CD. Cadmium-induced hepatic and renal injury in chronically exposed rats: likely role of hepatic cadmium- metallothionein in nephrotoxicity. Toxicol Appl Pharmacol 1985; 77: 414-426.
46. Liu J, Liu Y, Habeebu SS, Klaassen CD. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex. Toxicol Sci 1998; 46: 197-203.
47. Shaikh ZA, Vu TT, Zaman K. Oxidative stress as a mechanism of chronic cadmium-induced hepatotoxicity and renal toxicity and protection by antioxidants. Toxicol Appl Pharmacol 1999; 154: 256-263.
48. Suzuki Y. Cadmium metabolism and toxicity in rats after long-term subcutaneous administration. J Toxicol Environ Health 1980; 6: 469-482.
49. Arsalane K, Broeckaert F, Knoops B et al. Increased serum and urinary concentrations of lung Clara cell protein in rats acutely exposed to ozone. Toxicol Appl Pharmacol 1999; 159: 169-174.
50. Lee YH, Shaikh ZA, Tohyama C. Urinary metallothionein and tissue metal levels of rats injected with cadmium, mercury, lead, copper or zinc. Toxicology 1983; 27: 337-345.
51. Edwards JR, Diamantakos EA, Peuler JD et al. A novel method for the evaluation of proximal tubule epithelial cell viability in the intact rat kidney using ethidium homodimer. BMC Physiol 2007; 7: 1.
52. Cherian MG, Goyer RA, aquerriere-Richardson L. Cadmium-metallothionein- induced nephropathy. Toxicol Appl Pharmacol 1976; 38: 399-408.
53. Nordberg GF. Modulation of metal toxicity by metallothionein. Biol Trace Elem Res 1989; 21: 131-135.
54. Webb M. Role of metallothionein in cadmium metabolism. Cadmium, Hanbook of Experimental Pharmacology (vol 80). In: Foulkes EC (ed). Springer-Verlag: New York, 1986 pp 281-337.
55. Goyer RA, Miller CR, Zhu SY, Victery W. Non-metallothionein-bound cadmium in the pathogenesis of cadmium nephrotoxicity in the rat. Toxicol Appl Pharmacol 1989; 101: 232-244.
56. Squibb KS, Fowler BA. Intracellular metabolism and effects of circulating cadmium-metallothionein in the kidney. Environ Health Perspect 1984; 54: 31-35.
57. Squibb KS, Pritchard JB, Fowler BA. Cadmium-metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding. J Pharmacol Exp Ther 1984; 229: 311-321.
58. Tohyama C, Shaikh ZA. Metallothionein in plasma and urine of cadmium-exposed rats determined by a single-antibody radioimmunoassay. Fundam Appl Toxicol 1981; 1: 1-7.
59. Singh G, Katyal SL, Gottron SA. Antigenic, molecular and functional heterogeneity of Clara cell secretory proteins in the rat. Biochim Biophys Acta 1985; 829: 156-163.
60. Singh G, Katyal SL. Clara cell proteins. Ann NY Acad Sci 2000; 923: 43-58.
61. Bernard A, Lauwerys R. Low-molecular-weight proteins as markers of organ toxicity with special reference to Clara cell protein. Toxicol Lett 1995; 77: 145-151.
62. Van ME, Dumont X, Bernard A. CC16 as a marker of lung epithelial hyperpermeability in an acute model of rats exposed to mainstream cigarette smoke. Toxicol Lett 2005; 159: 115-123.
63. Halatek T, Gromadzinska J, Wasowicz W, Rydzynski K. Serum clara-cell protein and beta2-microglobulin as early markers of occupational exposure to nitric oxides. Inhal Toxicol 2005; 17: 87-97.
64. Cresswell P, Springer T, Strominger JL et al. Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci USA 1974; 71: 2123-2127.
65. Kobryn A, Pacsa A, White AG et al. Are peripheral blood lymphocytes the source of elevated B-2-microglobulin in renal transplant recipients? Transplant Proc 1989; 21: 302-303.
66. O'Bryan MK, Cheng CY. Purification and cellular localization of beta2-microglobulin in the testis. Life Sci 1997; 61: 487-494.
67. Poulik MD. beta2-Microglobulin: present status. Prog Clin Biol Res 1976; 5: 155-177.
68. Poulik MD, Gold P, Shuster J. beta 2-Microglobulin: methods and clinical applications. CRC Crit Rev Clin Lab Sci 1979; 10: 225-245.
69. Prozialeck WC, Lamar PC, Lynch SM. Cadmium alters the localization of N-cadherin, E-cadherin, and beta-catenin in the proximal tubule epithelium. Toxicol Appl Pharmacol 2003; 189: 180-195.
70. Prozialeck WC. Evidence that E-cadherin may be a target for cadmium toxicity in epithelial cells. Toxicol Appl Pharmacol 2000; 164: 231-249.
71. Jacquillet G, Barbier O, Cougnon M et al. Zinc protects renal function during cadmium intoxication in the rat. Am J Physiol Renal Physiol 2006; 290: F127-F137.
72. Park KM, Byun JY, Kramers C et al. Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003; 278: 27256-27266.
73. Davis JW, Goodsaid FM, Bral CM et al. Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity. Toxicol Appl Pharmacol 2004; 200: 16-26.
74. Han WK, Bailly V, Abichandani R et al. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62: 237-244.
75. Shoucri RM, Pouliot M. Some observations on the kinetics of the Jaffe reaction for creatinine. Clin Chem 1977; 23: 1527-1530.
76. de Borst MH, van Timmeren MM, Vaidya VS et al. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Renal Physiol 2007; 292: F313-F320.
77. van Timmeren MM, Bakker SJ, Vaidya VS et al. Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol 2006; 291: F456-F464.
78. Tang W, Kido T, Gross WA et al. Measurement of cadmium-induced metallothionein in urine by ELISA and prevention of overestimation due to polymerization. J Anal Toxicol 1999; 23: 153-158.
79. Halatek T, Hermans C, Broeckaert F et al. Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur Respir J 1998; 11: 726-733.
80. Pearson CA, Lamar PC, Prozialeck WC. Effects of cadmium on E-cadherin and VE-cadherin in mouse lung. Life Sci 2003; 72: 1303-1320.
81. Bernard A, Hermans C. Biomonitoring of early effects on the kidney or the lung. Sci Total Environ 1997; 199: 205-211.
82. Zar JH. Biostatistical Analysis. 3rd ed. Prentice Hall: Upper Saddle River, NJ, 1996, pp 197-199.